t has been proposed that Fas-mediated apoptosis is a feature of atherogenesis, 1-3 atherosclerotic plaque instability, 4 allograft arteriopathy 5 and the acute inflammatory response to cytokines. 6 Fas (also called APO-1 or CD95) is a type I membrane protein belonging to the tumor necrosis factor receptor family that induces a death signal when bound to its ligand (FasL). 7 Fas is ubiquitously expressed, whereas the expression of FasL, which is a membrane-bound factor, is typically confined to inflammatory cells and the tissues that routinely encounter them. 8, 9 Transmission of a death signal via this cascade, even when the receptors are bound, depends on endogenous regulators of proteolytic activation. For example, systemic administration of a Fas-activating antibody in normal animals fails to induce apoptosis in the vessel wall. 10 Although much is known about the Fas-mediated signaling transduction, the precise mechanisms that determine the Fas sensitivity of human vascular endothelial cells are currently unknown.
It is firmly established that elevated plasma concentrations of lowdensity lipoprotein (LDL) are associated with accelerated atherogenesis, and clinical trials demonstrate that LDL-lowering treatments reduce the risk of death in patients with coronary artery disease. [11] [12] [13] Oxidized (Ox)-LDL, and its lipid constituent, has numerous detrimental effects on endothelial cell function including the induction of apoptosis. 14, 15 In macrophages, several different molecules have been shown to support the cellular uptake of Ox-LDL, but in vascular endothelial cells, previous studies have suggested that endothelial uptake of modified forms of LDL, including Ox-LDL, appears to depend on cell-surface receptors, which may be encoded by genes different from those expressed in macrophages. The lectin-like oxidized LDL receptor-1 (LOX-1) is a receptor for Ox-LDL that was initially cloned from cultured vascular endothelial cells. 16 It can support binding, internalization, and degradation of Ox-LDL. 17 The purpose of the present study was to examine the influence of Ox-LDL on Fas-mediated apoptosis, especially focusing on the involvement of LOX-1.
Methods

Lipoprotein Isolation and Ox-LDL Synthesis
LDL (density (d)=1.019-1.063 g/ml) was separated from normal human plasma by preparative ultracentrifugation as described previously. 18 After plasma was obtained, EDTA (100 mol/ml, serum) and gentamycin (2 drops) were added. The protein concentration was determined by the modified Lowry assay method. Native LDL (nLDL; d= 1.019-1.063 g/ml) was isolated by sequential ultracentrifugation 65,000 rpm for 4 h 20 min in a NaBr gradient. Native 
Cell Culture
Human umbilical vascular endothelial cells (HUVECs) were obtained from Clonetics Human Cell Systems (San Diego, CA, USA) and cultured in endothelial cell growth medium (EGM-MV) containing 2% fetal bovine serum (FBS), 10 ng/ml human epithelial growth factor (EGF), 1.0 g/ml hydrocortisone, and 12 g/ml bovine brain extract. After being starved in basal medium containing 1% FBS for 24 h before LDL addition, HUVECs were treated for 24 h with Ox-LDL in different concentrations (10, 20 , 40 g/ml), and/or CH11 (1 g/ml: agonistic anti-Fas antibody, MBL, Nagoya, Japan), z-VAD.fmk (10 mol/L: IDUN Pharm, CA, USA). Some groups of cells were pretreated with a blocking antibody to LOX-1 (gift of T. Sawamura, Osaka, Japan) for 2 h.
Cell Death ELISA
A quantitative enzyme-linked immunoassay that detects DNA fragments was used according to the manufacturer's instructions. 19 The assay detects mono-and oligonucleosomal DNA using the cytoplasmic fractions of cell lysates. Briefly, anti-histone antibody was coated onto a microtiter plate. After a washing step, the wells were incubated with 200 l of incubation buffer for 30 min. The wells were again washed and incubated with 100 l of sample for 90 min at room temperature. Following another wash step, the wells were then washed and incubated with 100 l of anti-DNA peroxidase for additional 90 min. Addition of substrate solution produced a color change after 15 min. This color change was compared with a blank well with substrate added. The plate was read at 405 nm on an automated plate reader. The assay can detect apoptotic DNA from as little as 40 cells per well.
Flow Cytometry
Cell surface Fas was analyzed by flow cytometry. HUVECs were incubated with Ox-LDL in different concentrations (10, 20 , 40 g/ml) for 12 h, then with fluorescein isothiocyanate-conjugated anti-human monoclonal Fas antibody (Alexis Biochemicals) for 30 min at 4°C. The FACS calibur system (Becton Dickson, Mountain View, CA, USA) was used for the analysis. The levels of expression of Fas were evaluated using fluorescence intensity, which was calculated as the geometric mean fluorescence compared with control wells.
Reverse Transcriptase-Multiplex Polymerase Chain Reaction (RT-MPCR) for Fas and Fas-Related mRNA Expression
Total RNA (10 g) was extracted from cultured HUVECs using RNeasy MiniKit (Qiagen, CA, USA) and the reverse transcription reaction was performed (RNA PCR Kit (AMV) Ver.2.1 Takara, Kyoto, Japan). Reverse-transcribed material (5 l) was amplified with Taq DNA polymerase (5 U/ L, Takara, Kyoto, Japan) using a human apoptosis genes set-4 MPCR kit (MBI, San Francisco, CA, USA) according to the manufacturer's instructions. This human apoptosis genes set-4 MPCR kit is a quick and simple method of analyzing human Fas, FasL, FADD, FLICE, and GAPDH gene expression by amplifying all the genes under the same conditions. 20 We evaluated the PCR reaction with different cycles (ie, 28 and 30 cycles) to verify its cycle dependency. The RT-MPCR-amplified samples were visualized on 2% agarose gels using 0.5 g/ml ethidium bromide.
Statistical Analysis
Data are expressed as mean ± SEM. Statistical analysis was performed using ANOVA with Scheffe's t test. Statistical significance was established at p<0.05.
Results
Ox-LDL Sensitizes Fas-Mediated Apoptosis in HUVECs
First, to fully examine the effect of Ox-LDL on the viability of HUVECs, they were treated with Ox-LDL (40 g/ml) and then subjected to cell death ELISA. The addition of Ox-LDL to the HUVECs did not result in a significant change of apoptosis (Fig 1) . Next, to elucidate whether Ox-LDL activates the Fas death pathway, cultured HUVECs were incubated with combinations of agonistic anti-Fas antibody (CH11) in the presence or absence of Ox-LDL. Typically, endothelial cells are resistant to Fas-mediated cell death in response to ligation of cell surface Fas with CH11. Interestingly, incubation with Ox-LDL dosedependently permitted the agonistic anti-Fas antibody (CH11) to trigger apoptosis (Fig 1) . z-VAD.fmk, a pancaspase inhibitor, significantly blocked the production of oligonucleosome compared with cells treated with CH11 and Ox-LDL (40 g/ml) (p<0.01) (Fig 1) .
Effect of Ox-LDL on the Expression of Death-Regulating Genes in HUVECs
To examine whether the effect of Ox-LDL on Fasinduced apoptosis was associated with the alteration in expression of the death-regulating genes, the amounts of Fas, FLICE, and FADD mRNA in HUVECs following Ox-LDL treatment were assessed by RT-Multiplex PCR. Incubation of HUVECs with Ox-LDL for 6 h did not lead to any significant change in the expression of the death mediators (Fig 2) and the amounts of mRNA were similar tendency in the different cycles (28 or 30 cycles).
Modification of Cell Surface Fas by Ox-LDL
Cells were incubated with several concentrations of Ox-LDL (10, 20, and 40 g/ml) for 12 h and then the amount of cell surface Fas was determined by flow cytometry. Compared with untreated cells, cells treated for 12 h with Ox-LDL dose-dependently revealed distinct shifts in the distribution of fluorescence for Fas (Fig 3A,B) .
Neutralizing Anti-LOX-1 Antibody Prevents Ox-LDLInduced Activation of Fas-Mediated Endothelial Cell Apoptosis
To determine whether LOX-1 was involved in the Ox-LDL-induced activation of Fas-mediated apoptosis in HUVECs, HUVECs were incubated with CH11 (1 g/ml) and Ox-LDL (40 g/ml) in the presence or absence of a neutralizing anti-LOX-1 antibody. Before using the antibody in the experiments, we confirmed its ability to block the cellular uptake of Ox-LDL in Chinese hamster ovary cells that stably expressed bovine LOX-1 (data not shown). In the cell death ELISA assay, DNA fragmentation induced by Ox-LDL and agonistic Fas antibody was significantly decreased by incubation with the neutralizing antibody for LOX-1 (Fig 4) .
Neutralizing Antibody for LOX-1 Inhibits Ox-LDL-Induced Modulation of Surface Fas Expression in HUVECs
In HUVECs, Ox-LDL increased surface Fas expression in a concentration-dependent manner. To test whether LOX-1 mediated this increase in surface Fas in HUVECs, flow cytometry were performed in the presence of the anti-LOX-1 neutralizing antibody; the increase in the cell surface Fas induced by Ox-LDL in HUVECs was inhibited (Fig 5) , suggesting that LOX-1-mediated binding or uptake of Ox-LDL may increase the amount of surface Fas. 
Discussion
Vascular endothelial cells in culture 21 and in vivo 22 internalize and degrade Ox-LDL through a putative receptor-mediated pathway that does not seem to involve the classic macrophage scavenger receptor. Sawamura et al cloned the endothelial receptor for Ox-LDL (LOX-1), 16 which is a member protein that belongs structurally to the C-type selectin family and is expressed in vivo in vascular endothelium and in vascular-rich organs. Li et al have recently identified the presence of LOX-1 in cultured human coronary artery endothelial cells and demonstrated that Ox-LDL upregulates the expression of LOX-1 mRNA and protein. 23 Although the endothelial cell activation elicited by Ox-LDL and its lipid constituents has been implicated in atherogenesis, the effects of Ox-LDL binding or uptake through LOX-1 on the Fas signaling pathway in vascular endothelial cells remain to be clarified. In the present study, we demonstrated that Ox-LDL sensitizes Fas-mediated apoptosis in human vascular endothelial cells via surface Fas upregulation through Ox-LDL/LOX-1 interactions.
Although vascular endothelial cells express functional FasL and detectable Fas on their cell surface, they are resistant to Fas-mediated apoptosis under normal conditions. 24 Sata et al has reported that Ox-LDL induces endothelial cell suicide by sensitizing endothelial cells to Fas-mediated apoptosis; 25 however, the concentration of Ox-LDL used in their study (Ox-LDL: 300 g/ml) was not physiological and therefore the physiological role of Ox-LDL in Fas-mediated apoptosis remains unclear. In the present study, when we used lower concentrations of Ox-LDL (10-40 g/ml), we observed the sensitization of Ox-LDL to Fas-mediated apoptosis via surface Fas upregulation. Although it is unknown whether the increase in cell surface Fas is sufficient to trigger the death of human vascular endothelial cells by either FasL or agonistic Fas Ab, there is evidence that elevation of cell surface Fas correlates with the altered susceptibility of some cell types to FasL. 26 Because Fas sensitivity can be determined by down-stream events of the receptor, 27 we investigated whether Ox-LDL modified the transcriptional levels of FADD, and FLICE (procaspase-8). Incubation of HUVECs with Ox-LDL for 6 h did not lead to any significant change in the expression of the death mediators.
Study Limitations
There are several caveats on the interpretation of our data. First, it is not clear why there are different expression patterns of Fas; that is, its transcriptional expression and protein expression. It has been reported that Fas interacts with the ubiquitin-conjugating enzyme and that interaction may be directly involved in the ubiquitin-dependent degradation of Fas by proteasome. 28, 29 Interestingly, Vieira et al 30 demonstrated that incubation of cells with Ox-LDL induces ubiquitination of cell proteins and degradation of proteasome activity (ie, early activation followed by late inhibition). It seems that inhibition of proteasome activity by Ox-LDL may be implicated in the upregulation of surface Fas protein in HUVECs through mechanisms that remain to be elucidated.
Second, we examined several cell death modulating factors such as FLICE, Fas, and FADD by RT-PCR, but there are always quantitative problems with that method. However, when we have examined the PCR reaction with 2 different cycles, the results from both conditions had a similar tendency. Therefore, it is less likely that the PCR reaction was saturated.
Third, many molecules are potentially involved in the sensitization of the Fas-signaling pathway, such as c-FLIP 24, 31 and the IAP family. 32, 33 Although the present study has shown that Ox-LDL sensitized Fas-mediated endothelial cell apoptosis by upregulating cell surface expression of Fas, we can not exclude the involvement of other molecules.
Finally, it has been reported that the cell surface expression of FasL, but not Fas, is upregulated by treatment with Ox-LDL and thereby contributes to Ox-LDL-induced apoptosis. 1 In contrast, we did not detect increased expression of FasL, but cell surface expression of Fas was found to be increased after exposure to Ox-LDL. A potential explanation for the discrepancy between the 2 studies is the concentrations of Ox-LDL (150 g/ml vs 40 g/ml). Another study has shown that a modest concentration of Ox-LDL (20 g/ml) significantly enhanced hypoxia -reoxygenationmediated apoptosis of cultured human coronary arterial endothelial cells. 34 Importantly, upregulation of Fas protein expression appears to play a critically important roles in this process. 34 
Conclusion
The present study has revealed that LOX-1 mediates the Ox-LDL-induced augumentation of Fas-mediated apoptosis in HUVECs, at least in part, through an increase in surface Fas expression. Further studies related to the molecular mechanisms linking the Ox-LDL/LOX-1 interaction to the altered expression of surface Fas may provide new insights into the pathogenesis of atherosclerosis.
